Results for 'CRISPR Therapeutics' Create an alert

CRISPR Therapeutics says it’s ready to test a CRISPR-based therapy on people.
Last week, Crispr Therapeutics announced it has asked regulators in Europe for permission to trial a cure for the disease beta thalassemia
BREAKING: CRISPR Therapeutics, which aims to use gene editing to treat disease, is planning a $90 million IPO:
Coming soon: #CRISPR’s clinical debut. Vertex Pharmaceuticals and CRISPR Therapeutics will begin the first human studies of a CRISPR therapy in the U.S. and Europe next year.
A new CRISPR-engineered #cancer #model to test therapeutics @broadinstitute @CellStemCell
Total(1) => 0.092314958572388 f_f_QM(2) => 0.08042573928833 indS(2) => 0.018936157226562 indM(2) => 0.060785055160522 indM_1(2) => 0.0053889751434326 indM_2(2) => 0.001060962677002 indM_4(2) => 0.0090479850769043 indM_5(2) => 0.01287317276001 indM_6(2) => 0.0046041011810303 indM_7(2) => 0.0047938823699951 indM_8(2) => 0.0011589527130127 f_f_pTL(2) => 0.0037739276885986 f_f_dT(16) => 0.0035607814788818